T1	Intervention 77 122	fluconazole versus intravenous amphotericin B
T2	Intervention 0 76	Antifungal prophylaxis during remission induction therapy for acute leukemia
T3	Intervention 824 1023	randomly were assigned to receive antifungal prophylaxis with AMB (0.5 mg/kg three times weekly) or FLU (400 mg daily). Trimethoprim-sulfamethoxazole was administered as an antibacterial prophylaxis.
T4	Intervention 1024 1269	Prophylaxis was continued until the patient achieved complete remission or was treated for 8 weeks without antileukemic response. Prophylaxis was discontinued if the patient experienced a possible or proven fungal infection or a serious toxicity
